Intravenous co-trimoxazole therapy in serious infections.
The intravenous therapy with co-trimoxazole was used to control serious sepsis in 15 patients in the intensive care unit of a large metropolitan hospital. Co-trimoxazole was found to be a safe, effective, and eminently satisfactory alternative to the present vogue treatments of serious, bacteriologically undiagnosed infections.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000627:therapeutic use*; D014295:Trimethoprim / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole